On September 23, 2026, HENGRUI PHARMA (01276) executed a share repurchase, investing RMB 11.3723 million to buy back 250,000 A-shares. The buyback price ranged between RMB 45.42 and RMB 45.54 per share, as disclosed in a recent company announcement.
The repurchase reflects the company's move to enhance shareholder value and signal confidence in its stock performance.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.